Vaxart, Inc. (VXRT) AI Dilution Summary
Updated Nov 10, 2026
Estimated cash was $65,544,000 as of 2026-09-30, the last reported balance-sheet date. The active funding channel is the ATM program with Citizens JMP Securities, LLC and B. Riley Securities, Inc., authorised to $49,772,479 with $48,400,000 remaining. It has sold 382,700 shares since the program began, through 2026-09-30, and sales after 2026-09-30 are not yet reported.